Heidelberg Pharma AG/ DE000A11QVV0 /
| 12/22/2020 12:00:00 AM | Chg. - | Volume | Bid9:02:12 AM | Ask9:02:12 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 7.18EUR | - | 48 Turnover: - |
-Bid Size: - | -Ask Size: - | 77.92 mill.EUR | 0.00% | - |
Fundamentals
| FY 2021 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.80 EUR | 31.15% |
| EPS Diluted: | -0.80 EUR | 31.15% |
| Revenues per Share: | 0.05 EUR | -81.82% |
| Book Value per Share: | 0.20 EUR | -52.79% |
| Cash Flow per Share: | -0.78 EUR | 35.06% |
| Dividend per Share: | 0.00 EUR | - |
| Total | in mill. | |
| Revenues: | 1.70 EUR | -80.00% |
| Net Income: | -26.10 EUR | 41.85% |
| Operating Cash Flow: | -26.60 EUR | - |
| Cash and Cash Equivalents: | 6.10 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 45.84 | 104.14 |
| P/BV ratio: | 11.63 | 26.42 |
| P/CF Ratio: | -2.93 | -6.66 |
| PEG: | -0.09 | - |
| Earnings Yield: | -35.09% | -15.44% |
| Dividend Yield: | 0.00% | 0.00% |
| Market Capitalization | ||
| Market Capitalization: | 77.92 mill. EUR | 177.03 mill. EUR |
| Free Float Market Cap.: | 53.23 mill. EUR | 120.93 mill. EUR |
| Market Cap. / Employee: | 811,680 EUR | 1.84 mill. EUR |
| Shares Outstanding: | 46.58 mill. | |
Profitability
| Gross Profit Margin: | -656.00% |
| EBIT Margin: | -1,505.88% |
| Net Profit Margin: | -1,535.29% |
| Return on Equity: | -389.55% |
| Return on Assets: | -120.28% |
Financial Strength
| Liquidity I / Cash Ratio: | 40.94% |
| Liquidity II / Quick Ratio: | 47.65% |
| Liquidity III / Current Ratio: | 60.40% |
| Debt / Equity Ratio: | 223.88% |
| Dynam. Debt / Equity Ratio: | -56.39% |
Efficiency
| Employees: | 96 |
| Personal Expenses / Employee: | 84,916.67 EUR |
| Revenues / Employee: | 17,708.33 EUR |
| Net Income / Employee: | -271,875.00 EUR |
| Total Assets / Employee: | 226,041.67 EUR |
| * Fiscal Year End: | 11/30/2021 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
